lithium10q-5_5.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-Q
(Mark
One)
x
|
QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
For the
Quarterly Period ended September 30, 2008
OR
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934.
|
For the
transition period from
to
Commission
File Number 1-10446
LITHIUM
TECHNOLOGY CORPORATION
(Name
of Issuer in Its Charter)
DELAWARE
|
|
13-3411148
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
5115
CAMPUS DRIVE, PLYMOUTH MEETING, PENNSYLVANIA 19462
(Address
of Principal Executive Offices) (Zip Code)
(610)
940-6090
(Issuer’s
Telephone Number, Including Area Code)
Indicate
by check mark whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the past
12 months (or for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes o No x
Indicate
by check mark whether the registrant is a large accelerates filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of “large accelerated filer,” “accelerated filer” and “smaller
reporting company” in rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer o
|
|
Accelerated
filer o
|
|
Non-accelerated
filer o
|
|
Smaller reporting company x
|
|
|
|
|
(Do
not check if a smaller reporting company)
|
|
|
Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes o No x
APPLICABLE
ONLY TO CORPORATE ISSUERS
State the
number of shares outstanding of each of the issuer’s classes of common equity,
as of the latest practicable date: As of April 20, 2009, 745,924,782 shares of
common stock.
LITHIUM
TECHNOLOGY CORPORATION AND SUBSIDIARIES
FORM
10-Q
FOR
THE QUARTER ENDED SEPTEMBER 30, 2008
INDEX
|
|
|
|
|
|
|
|
|
PAGE
|
|
|
|
|
|
|
|
|
ITEM 1.
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
|
|
|
|
|
|
4
|
|
|
|
|
|
|
|
5
|
|
|
|
|
|
|
|
6
|
|
|
|
ITEM 2.
|
|
|
|
16
|
|
|
|
ITEM 3.
|
|
|
|
26
|
|
|
|
ITEM 4T.
|
|
|
|
26
|
|
|
|
|
|
|
|
|
|
|
|
ITEM 1.
|
|
|
|
27
|
|
|
|
ITEM 1A.
|
|
|
|
27
|
|
|
|
ITEM 2.
|
|
|
|
27
|
|
|
|
ITEM 3.
|
|
|
|
27
|
|
|
|
ITEM 4.
|
|
|
|
27
|
|
|
|
ITEM 5.
|
|
|
|
28
|
|
|
|
ITEM 6.
|
|
|
|
28
|
FINANCIAL
INFORMATION
CONDENSED
CONSOLIDATED BALANCE SHEETS
Condensed Consolidated Balance
Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2008
|
|
|
December 31,
2007
|
|
|
|
(unaudited)
|
|
|
(audited)
|
|
ASSETS
|
|
|
|
|
|
|
CURRENT
ASSETS:
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$ |
296,000 |
|
|
$ |
4,458,000 |
|
Accounts
receivable
|
|
$ |
241,000 |
|
|
$ |
527,000 |
|
Inventories
|
|
$ |
2,326,000 |
|
|
$ |
3,320,000 |
|
Prepaid expenses and other current
assets
|
|
$ |
409,000 |
|
|
$ |
703,000 |
|
Total current
assets
|
|
$ |
3,272,000 |
|
|
$ |
9,008,000 |
|
Property and equipment,
net
|
|
$ |
7,470,000 |
|
|
$ |
7,789,000 |
|
Related party
receivables
|
|
$ |
277,000 |
|
|
$ |
579,000 |
|
Other
assets
|
|
|
|
|
|
$ |
155,000 |
|
Total
assets
|
|
$ |
11,019,000 |
|
|
$ |
17,531,000 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS
DEFICIT
|
|
|
|
|
|
|
|
|
CURRENT
LIABILITIES:
|
|
|
|
|
|
|
|
|
Bank debt
|
|
$ |
99,000 |
|
|
|
|
|
Accounts
payable
|
|
$ |
2,681,000 |
|
|
$ |
2,704,000 |
|
Related party accounts
payable
|
|
|
|
|
|
$ |
1,623,000 |
|
Accrued
salaries
|
|
$ |
241,000 |
|
|
$ |
83,000 |
|
Accrued
interest
|
|
$ |
701,000 |
|
|
$ |
504,000 |
|
Current portion of long term
debt
|
|
$ |
5,463,000 |
|
|
$ |
5,411,000 |
|
Related party
debt
|
|
|
|
|
|
$ |
6,332,000 |
|
Other current liabilities and
accrued expenses
|
|
$ |
1,307,000 |
|
|
$ |
2,245,000 |
|
Warrant
liability
|
|
$ |
890,000 |
|
|
$ |
15,550,000 |
|
Total current
liabilities
|
|
$ |
11,382,000 |
|
|
$ |
34,452,000 |
|
|
|
|
|
|
|
|
|
|
LONG TERM
DEBT
|
|
|
|
|
|
|
|
|
Related party
debt
|
|
$ |
5,254,000 |
|
|
|
|
|
|
|
$ |
3,776,000 |
|
|
|
|
|
Total Long Term
Debt
|
|
$ |
9,030,000 |
|
|
$ |
- |
|
Total
liabilities
|
|
$ |
20,412,000 |
|
|
$ |
34,452,000 |
|
COMMITMENTS AND
CONTINGENCIES
|
|
|
|
|
|
|
|
|
STOCKHOLDERS
DEFICIT
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Preferred stock B, par
value $.01 per share, authorized, issued and outstanding: 100,000 at
September 30, 2008 and December 31, 2007
|
|
$ |
1,000 |
|
|
$ |
1,000 |
|
Convertible Preferred stock C, par
value $.01 per share, authorized 300,000, issued and outstanding: 233,200
at September 30, 2008 and 218,183 at December 31,
2007
|
|
$ |
3,000 |
|
|
$ |
3,000 |
|
Common stock, par value $.01 per
share, authorized - 750,000,000 at September 30, 2008 and December 31,
2007 respectively; issued and outstanding - 745,924,782 and
630,924,782
|
|
$ |
7,459,000 |
|
|
$ |
6,309,000 |
|
Additional paid-in
capital
|
|
$ |
117,971,000 |
|
|
$ |
111,998,000 |
|
Cumulative translation
adjustments
|
|
$ |
(1,784,000 |
) |
|
$ |
(4,172,000 |
) |
Accumulated
deficit
|
|
$ |
(133,043,000 |
) |
|
$ |
(131,059,000 |
) |
Total stockholders
deficit
|
|
$ |
(9,393,000 |
) |
|
$ |
(16,920,000 |
) |
Total liabilities and stockholders
deficit
|
|
$ |
11,019,000 |
|
|
$ |
17,532,000 |
|
See
accompanying notes to condensed consolidated financial statements.
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
|
|
NINE
MONTHS ENDED
|
|
|
THREE
MONTHS ENDED
|
|
|
|
SEPTEMBER
30,
|
|
|
SEPTEMBER
30,
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
|
(unaudited)
|
|
REVENUES
|
|
|
|
|
|
|
|
|
|
|
|
|
Products
and services sales
|
|
$ |
3,602,000 |
|
|
$ |
2,024,000 |
|
|
$ |
1,306,000 |
|
|
$ |
843,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
COSTS
AND EXPENSES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost
of goods sold
|
|
$ |
6,443,000 |
|
|
$ |
2,602,000 |
|
|
$ |
3,175,000 |
|
|
$ |
1,034,000 |
|
Engineering,
research and development
|
|
$ |
1,394,000 |
|
|
$ |
2,320,000 |
|
|
$ |
-95,000 |
|
|
$ |
690,000 |
|
General
and administrative
|
|
$ |
5,401,000 |
|
|
$ |
3,930,000 |
|
|
$ |
2,297,000 |
|
|
$ |
1,130,000 |
|
Warrant
expense/change in fair value (income)
|
|
$ |
-12,173,000 |
|
|
$ |
16,242,000 |
|
|
$ |
-3,750,000 |
|
|
$ |
875,000 |
|
Stock
based compensation expense
|
|
$ |
- |
|
|
|
|
|
|
$ |
- |
|
|
|
|
|
Sales
and marketing
|
|
$ |
537,000 |
|
|
$ |
318,000 |
|
|
$ |
-46,000 |
|
|
$ |
236,000 |
|
Depreciation
|
|
$ |
331,000 |
|
|
$ |
693,000 |
|
|
$ |
-25,000 |
|
|
$ |
114,000 |
|
Loss
(Gain) on sale of tangible assets
|
|
$ |
- |
|
|
|
|
|
|
$ |
- |
|
|
|
|
|
Total
costs and expenses
|
|
$ |
1,933,000 |
|
|
$ |
26,105,000 |
|
|
$ |
1,556,000 |
|
|
$ |
4,079,000 |
|
Loss
from operations
|
|
$ |
1,669,000 |
|
|
$ |
-24,081,000 |
|
|
$ |
-250,000 |
|
|
$ |
-3,236,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER
INCOME (EXPENSE)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
expense, net of interest income
|
|
$ |
-580,000 |
|
|
$ |
-1,588,000 |
-63%
|
|
$ |
-370,000 |
|
|
$ |
-252,000 |
|
Interest
expense related to amortization of discount on convertible
debt
|
|
$ |
-3,827,000 |
|
|
$ |
-1,633,000 |
|
|
$ |
-55,000 |
|
|
$ |
-58,000 |
|
Other
|
|
$ |
651,000 |
|
|
$ |
-18,000 |
|
|
$ |
936,000 |
|
|
$ |
33,000 |
|
Total
other income (expense)
|
|
$ |
-3,756,000 |
|
|
$ |
-3,239,000 |
|
|
$ |
511,000 |
|
|
$ |
-277,000 |
|
NET
INCOME (LOSS)
|
|
$ |
-2,087,000 |
|
|
$ |
-27,320,000 |
|
|
$ |
261,000 |
|
|
$ |
-3,513,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends
on preferred shares
|
|
|
|
|
|
$ |
-58,000 |
|
|
|
|
|
|
|
|
|
Discount
related to beneficial conversion feature of Preferred
Stock
|
|
|
|
|
|
$ |
-11,274,000 |
|
|
$ |
2,147,000 |
|
|
$ |
-137,000 |
|
NET
INCOME (LOSS) TO COMMON SHAREHOLDERS
|
|
$ |
-2,087,000 |
|
|
$ |
-38,652,000 |
|
|
$ |
2,408,000 |
|
|
$ |
-3,650,000 |
|
OTHER
COMPREHENSIVE INCOME (LOSS)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Currency
translation adjustments
|
|
$ |
103,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
COMPREHENSIVE
INCOME (LOSS)
|
|
$ |
-1,984,000 |
|
|
$ |
-38,652,000 |
|
|
$ |
2,408,000 |
|
|
$ |
-3,650,000 |
|
Weighted
average number of common shares outstanding:
|
|
|
1,593,027,896 |
|
|
|
1,124,583,396 |
|
|
|
1,593,027,896 |
|
|
|
1,297,721,107 |
|
Basic
and diluted net (loss)/income per share
|
|
$ |
-0.0012 |
|
|
$ |
-0.0344 |
|
|
$ |
0.0015 |
|
|
$ |
-0.0028 |
|
See
accompanying notes to condensed consolidated financial statements.
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)
|
|
NINE
MONTHS ENDED
|
|
|
|
SEPTEMBER
30,
|
|
|
|
2008
|
|
|
2007
|
|
CASH
FLOW FROM OPERATING ACTIVITIES
|
|
|
|
|
|
|
Net
Income / (Net loss)
|
|
$ |
-2,087,000 |
|
|
$ |
-27,320,000 |
|
Adjustments
|
|
|
|
|
|
|
|
|
Depreciation
expense
|
|
$ |
883,000 |
|
|
$ |
693,000 |
|
Warrant
income/change in fair value
|
|
$ |
-12,173,000 |
|
|
$ |
16,242,000 |
|
Interest
expense beneficial conversion feature
|
|
$ |
3,827,000 |
|
|
$ |
1,633,000 |
|
(Increase)/decrease
in assets
|
|
|
|
|
|
|
|
|
Inventories
|
|
$ |
201,000 |
|
|
$ |
-468,000 |
|
Accounts
receivable
|
|
$ |
176,000 |
|
|
$ |
-414,000 |
|
Prepaid
expenses and other assets
|
|
$ |
294,000 |
|
|
$ |
-206,000 |
|
Increase/(Decrease)
in liabilities
|
|
|
|
|
|
|
|
|
Accounts
payable & accrued expenses
|
|
$ |
332,000 |
|
|
$ |
-3,133,000 |
|
Other
current liabilities
|
|
$ |
-904,000 |
|
|
$ |
-140,000 |
|
Net
cash used in operating activities
|
|
$ |
-9,451,000 |
|
|
$ |
-13,113,000 |
|
CASH
FLOW FROM INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
Capital
Expenditures
|
|
$ |
-467,000 |
|
|
$ |
-1,273,000 |
|
Net
cash used in investing activities
|
|
$ |
-467,000 |
|
|
$ |
-1,273,000 |
|
CASH
FLOW FROM FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
Repayment
of debt
|
|
$ |
-2,858,000 |
|
|
|
|
|
Proceeds
from exercise of warrants
|
|
$ |
-2,487,000 |
|
|
$ |
-10,106,000 |
|
Proceeds
from borrowing
|
|
$ |
3,776,000 |
|
|
$ |
3,179,000 |
|
Proceeds
from equity issuance
|
|
$ |
7,123,000 |
|
|
$ |
19,569,000 |
|
Net
cash provided by financing activities
|
|
$ |
5,554,000 |
|
|
$ |
12,642,000 |
|
NET
INCREASE IN CASH
|
|
$ |
-4,364,000 |
|
|
$ |
-1,744,000 |
|
CURRENCY
EFFECTS ON CASH
|
|
$ |
103,000 |
|
|
$ |
47,000 |
|
CASH
AND CASH EQUIVALENTS, BEGINNING OF PERIOD
|
|
$ |
4,458,000 |
|
|
$ |
1,976,000 |
|
CASH
AND CASH EQUIVALENTS, END OF PERIOD
|
|
$ |
197,000 |
|
|
$ |
279,000 |
|
See
accompanying notes to consolidated financial statements.
AND
SUBSIDIARIES
NOTE
1—BASIS OF PRESENTATION
The
accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with accounting principles generally accepted in the
United States of America and rules and regulations of the Securities and
Exchange Commission (the “SEC”) applicable to interim periods. In the opinion of
management, all adjustments considered necessary for a fair presentation have
been included. These financial statements should be read in conjunction with the
Company’s financial statements included in the Company’s Annual Reports on Form
10-KSB filed with the Securities and Exchange Commission for the year ended
December 31, 2007. Operating results for the interim periods shown in this
report are not necessarily indicative of the results for the full
year.
NOTE
2—ORGANIZATION, BUSINESS OF THE COMPANY AND LIQUIDITY
In 2002,
Lithium Technology Corporation (“LTC” or the “Company”) closed share exchanges
in which LTC acquired ownership of 100% of GAIA Holding B.V. (“GAIA Holding”)
from Arch Hill Ventures, NV, a private company limited by shares, incorporated
under the laws of the Netherlands (“Arch Hill Ventures”), which is controlled by
Arch Hill Capital NV (“Arch Hill Capital”), a private company limited by shares,
incorporated under the laws of the Netherlands (the “Share Exchanges”). In
November 2004, Arch Hill Capital and Arch Hill Ventures transferred all LTC
securities owned by such entities to Stichting Gemeenschappelijk Bezit GAIA
(“Stichting GAIA”) and Stichting Gemeenschappelijk Bezit LTC (“Stichting LTC”),
entities controlled by Arch Hill Capital.
Subsequent
to the Share Exchanges, Arch Hill Capital effectively controls LTC. As a result,
the Share Exchanges have been accounted for as a reverse acquisition, whereby
for financial reporting purposes, GAIA Holding is considered the acquiring
company. Hence, the historical financial statements of GAIA Holding became the
historical financial statements of the Company and include the results of
operations of LTC only from the acquisition date of October 4,
2002.
GAIA
Holding, a private limited liability company incorporated under the laws of the
Netherlands, is the 100% beneficial owner of GAIA Akkumulatorenwerke GmbH
(“GAIA”). GAIA Holding was incorporated in 1990 and only had limited operations
until the acquisition of GAIA on February 12, 1999 (inception of
development stage). GAIA is a private limited liability company incorporated
under the laws of Germany. GAIA Holding’s ownership interest in GAIA is held
through certain trust arrangements.
The
Company was in the development stage from February 12, 1999 through
December 31, 2005. The year 2006 was the first year for which the Company
was considered an operating company and was no longer in development
stage.
The
Company considers itself to have one operating segment. The Company is an early
stage pilot-line production stage company that develops large format lithium-ion
rechargeable batteries to be used as a new power source for emerging
applications in the automotive, stationary power, and national security
markets.
The
Company’s operating plan seeks to minimize its capital requirements, but the
expansion of its production capacity to meet increasing sales and refinement of
its manufacturing process and equipment will require additional capital. The
Company expects that operating and production expenses will increase
significantly to meet increasing sales. For this reason the company restructured
its business starting Q3 2008, by abandoning its flat cell production activity
and streamlining its cylindrical cell production in Nordhausen Germany. Going
forward the US operation will assemble batteries to customer needs for the US
market. Batteries for the EU market will initially be assembled in Nordhausen
Germany. The Company has recently entered into a number of financing
transactions (see Notes 8 and 10) and is continuing to seek other financing
initiatives. The Company needs to raise additional capital to meet its working
capital needs, for the repayment of debt and for capital expenditures. Such
capital is expected to come from the sale of securities. The Company believes
that if it raises approximately $14 to $20 million in debt and equity financings
it would have sufficient funds to meet its needs for working capital, repayment
of debt and for capital expenditures over the next twelve months to meet
expansion plans.
No
assurance can be given that the Company will be successful in completing any
financings at the minimum level necessary to fund its capital equipment, debt
repayment or working capital requirements, or at all. If the Company is
unsuccessful in completing these financings, it will not be able to meet its
working capital, debt repayment or capital equipment needs or execute its
business plan. In such case the Company will assess all available alternatives
including a sale of its assets or merger, the suspension of operations and
possibly liquidation, auction, bankruptcy, or other measures. These conditions
raise substantial doubt about the Company’s ability to continue as a going
concern. The accompanying financial
statements do not include any adjustments relating to the recoverability of the
carrying amount of recorded assets or the amount of liabilities that might
result should the Company be unable to continue as a going
concern.
NOTE
3—SIGNIFICANT ACCOUNTING POLICIES
As of
September 30, 2008, there have been no material changes to any of our
significant accounting policies.
NOTE
4—OPERATING AND LIQUIDITY DIFFICULTIES AND MANAGEMENT’S PLANS TO
OVERCOME
Over the
past seven years, we have focused our unique extrusion-based manufacturing
process, large format cylindrical cell technology, large battery assembly
expertise, and market activities to concentrate on large-format, high rate
battery applications. Our commercialization efforts are focused on applying our
lithium-ion rechargeable batteries in the national security, transportation and
stationary power markets.
Our
operating plan seeks to minimize our capital requirements, but expansion of our
production capacity to meet increasing sales and refinement of our manufacturing
process and equipment will require additional capital. We expect that operating
and production expenses will increase significantly as we continue to ramp up
our production and continue our battery technology and develop, produce, sell
and license products for commercial applications. For this reason the company
restructured its business starting Q3 2008, by abandoning its flat cell
production activity and streamlining its cylindrical cell production in
Nordhausen Germany. Going forward the US operation will assemble batteries to
customer needs for the US market. Batteries for the EU market will initially be
assembled in Nordhausen Germany.
We have
entered into a number of financing transactions (see Notes 8 and 10). We are
continuing to seek other financing initiatives. We need to raise additional
capital to meet our working capital needs, for the repayment of debt and for
capital expenditures. Such capital is expected to come from the sale of
securities and debt financing. We believe that if we raise approximately $14 to
$20 million in debt and equity financings, we would have sufficient funds to
meet our needs for working capital and repayment of debt and for capital
expenditures over the next twelve months.
No
assurance can be given that we will be successful in completing any financings
at the minimum level necessary to fund our capital equipment, debt repayment or
working capital requirements, or at all. If we are unsuccessful in completing
these financings, we will not be able to meet our working capital, debt
repayment or capital equipment needs or execute our business plan. In such case
we will assess all available alternatives including a sale of our assets or
merger, the suspension of operations and possibly liquidation, auction,
bankruptcy, or other measures.
NOTE
5—INVENTORIES
Inventories
primarily include raw materials and auxiliary materials required for the
production process.
Inventories
at September 30, 2008 and December 31, 2007 are made up of the
following:
|
|
September
30, 2008
|
|
|
December
31, 2007
|
|
|
|
(unaudited)
|
|
|
(audited)
|
|
Finished
Goods
|
|
$ |
1,221,000 |
|
|
$ |
1,814,000 |
|
Work
In Process
|
|
$ |
344,000 |
|
|
$ |
757,000 |
|
Raw
Materials
|
|
$ |
761,000 |
|
|
$ |
749,000 |
|
|
|
$ |
2,326,000 |
|
|
$ |
3,320,000 |
|
NOTE
6—PROPERTY AND EQUIPMENT
Property
and equipment at September 30, 2008 and December 31, 2007 is
summarized as follows:
|
|
September
30, 2008
|
|
|
December
31, 2007
|
|
|
|
(unaudited)
|
|
|
(audited)
|
|
Land
and buildings
|
|
$ |
3,768,000 |
|
|
$ |
3,756,000 |
|
Technical
and laboratory equipment
|
|
$ |
8,590,000 |
|
|
$ |
8,864,000 |
|
Asset
under construction and equipment deposit
|
|
$ |
528,000 |
|
|
$ |
285,000 |
|
Office
equipment and other
|
|
$ |
1,055,000 |
|
|
$ |
987,000 |
|
Less:
Accumulated depreciation and amortization
|
|
$ |
-6,471,000 |
|
|
$ |
-6,103,000 |
|
|
|
$ |
7,470,000 |
|
|
$ |
7,789,000 |
|
Assets
under construction included equipment being constructed that was not yet placed
into service.
NOTE
7—INCOME TAXES
Dutch tax
legislation does not permit a Dutch parent company and its foreign subsidiaries
to file a consolidated Dutch tax return. Dutch resident companies are taxed on
their worldwide income for corporate income tax purposes at a statutory rate of
35%. No further taxes are payable on this profit unless that profit is
distributed. If certain conditions are met, income derived from foreign
subsidiaries is tax exempt in the Netherlands under the rules of the Dutch
“participation exemption”. However, certain costs such as acquisition costs and
interest on loans related to foreign qualifying participation’s are not
deductible for Dutch corporate income tax purposes, unless those cost are
attributable to Dutch taxable income. When income derived by a Dutch company is
subject to taxation in the Netherlands as well as in other countries, generally
avoidance of double taxation can be obtained under the extensive Dutch tax
treaty network or Dutch domestic law.
For
subsidiaries, local commercial and tax legislation contains provisions that may
imply more than one treatment for a transaction. Thus, management’s judgment of
the companies’ business activities and transactions may not coincide with the
interpretation of the tax authorities. In the event that a particular
transaction is challenged by the tax authorities the
subsidiaries
may incur penalties and taxes on present and past transactions. Management
believes that the financial statements adequately reflect the activities of the
subsidiaries.
Deferred
income taxes reflect the net effects of temporary differences between the
amounts of assets and liabilities for financial reporting purposes and the
amounts used for income tax purposes. The breakdown of the deferred tax asset as
of September 30, 2008 is as follows:
|
|
Foreign
|
|
|
Domestic
|
|
|
Total
|
|
Tax
loss carry forwards
|
|
$ |
28,743,000 |
|
|
$ |
17,569,000 |
|
|
$ |
46,312,000 |
|
Less
valuation allowance
|
|
$ |
-28,743,000 |
|
|
$ |
-17,569,000 |
|
|
$ |
-46,312,000 |
|
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
- |
|
As a
result of the Company’s continuing tax losses, the Company has recorded a full
valuation allowance against a net deferred tax asset. Additionally, the Company
has not recorded a liability for unrecognized tax benefits subsequent to the
adoption of FIN 48.
The last
nine years remain open to examination by the major taxing jurisdictions to which
the Company is subject as a result of not filing tax returns for certain of
those years.
NOTE
8—DEBT
|
|
September
30, 2008
|
|
|
December
31, 2007
|
|
Current
debt is summarized as follows:
|
|
|
|
|
|
|
Loans
From Financial Institutions
|
|
$ |
990,000 |
|
|
$ |
104,000 |
|
Silent
Partner loans-TBG
|
|
$ |
2,216,000 |
|
|
$ |
2,259,000 |
|
July
2007 10% Convertible Debenture, net of discount
|
|
$ |
3,247,000 |
|
|
$ |
3,048,000 |
|
June
2008, 9% Convertible Note, net of discount
|
|
$ |
3,776,000 |
|
|
|
|
|
Sub
total current debt
|
|
$ |
10,229,000 |
|
|
$ |
5,411,000 |
|
Related
party debt:
|
|
|
|
|
|
|
|
|
Subordinated
Loans from Archhill
|
|
$ |
1,627,000 |
|
|
$ |
6,272,000 |
|
Promissory
Note to Archhill
|
|
$ |
3,627,000 |
|
|
$ |
60,000 |
|
Sub
total Related party debt
|
|
$ |
5,254,000 |
|
|
$ |
6,332,000 |
|
Warrant
liability
|
|
$ |
890,000 |
|
|
$ |
15,550,000 |
|
Total
current debt
|
|
$ |
16,373,000 |
|
|
$ |
27,293,000 |
|
JULY
2007 10% CONVERTIBLE DEBENTURE
On
July 11, 2007, the European Subsidiaries Debt and accrued interest was
satisfied with the payment of €6 million and the issuance of a Company
convertible note in the principal amount of U.S. $3,247,106 (the “Convertible
Note”). The Convertible Note is convertible into shares of Company common stock
at $0.10 per share. The Convertible Note accrues interest at 10% per annum
and is due and payable on September 1, 2008. The Company has the right to
repay the Convertible Note at any time prior to maturity without penalty. The
Convertible Note will be secured by 90 million shares of Company common
stock. The Company did not pay any underwriting discounts or commissions in
connection with the issuance of the Convertible Note in this transaction.
Issuance of the Convertible Note was exempt from registration under
Section 4(2) of the Securities Act. The Convertible Note was issued to an
accredited investor in a private transaction without the use of any form of
general solicitation or advertising. The underlying securities are “restricted
securities” subject to applicable limitations on resale. As of
September 30, 2008 and December 31, 2007, $3,193,000 and $3,048,000
was outstanding under the convertible debenture net of debt discount of $54,000
and $199,000, respectively. As of September 30, 2008 and December 31,
2007, accrued interest of $317,000, and $154,000, respectively, was outstanding
under the Convertible Note. Upon issuance, the Company recorded a discount from
beneficial conversion feature of $325,000 that is amortized over the life of the
note using the effective interest method.
JUNE
2008 9% CONVERTIBLE NOTES
The
Company closed on a convertible debt financing with four institutional investors
from June 12, 2008 to September 30, 2008 (the “Lenders”) for a total
of Euros 2.60 million (approximately U.S. $5,757,000) including 57k€
(approximately U.S. $82,000) of accrued interest (the “June 2008
Financing”). The Company issued its convertible notes (the “Convertible Notes”)
to the Lenders in connection with the June 2008 Financing. The Convertible Notes
are convertible at $0.10 per share into Company common stock or any equity
securities issued by the Company after the date of issuance of the Convertible
Notes. The Convertible Notes accrue interest at 9% per annum and are due
and payable on September 30, 2011 (the “Maturity Date”). All obligations of
the Company under the Convertible Notes will be secured by security interests in
all of the tangible and intangible fixed assets, including real estate, of the
Company.
Prior to
the Maturity Date, the Convertible Notes are due and payable within three months
of a “Change in Control” of the Company or a “Financing”. “Change in Control” of
the Company is defined to have occurred if, at any time following the date of
the Convertible Notes: (A) any “person” or “group” (as such terms are used
in Sections 3(a)(9) and 13(d)(3) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”)) (other than the shareholders of the Company
identified in (1) Amendment No. 16/6 to Schedule 13D filed with
respect to the Company on April 29, 2008 and (2) Schedule 13D
filed with respect to the Company on June 2, 2008) becomes a “beneficial
owner” (as such term is used in Rule 13d-3 promulgated under the Exchange Act),
directly or indirectly, of securities of the Company representing 50% or more of
the combined voting power of the Company’s then outstanding securities;
(B) a change in “control” of the Company (as the term “control” is defined
in Rule 12b-2 or any successor rule promulgated under the Exchange Act) shall
have occurred; (C) the shareholders or the Board of Directors of the
Company approve a plan of complete liquidation of the Company or an agreement
for the sale or disposition by the Company of all or substantially all of the
Company’s assets; or (D) the shareholders or the Board of Directors of the
Company approve a merger or consolidation of the Company with any other
company,
other than a merger or consolidation which would result in the combined voting
power of the Company’s voting securities outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted
into voting securities of the surviving entity) more than 50% of the combined
voting power of the voting securities of the Company or such surviving entity
outstanding immediately after such merger or consolidation. “Financing” is
defined as the consummation by the Company or any of its subsidiaries of any
debt or equity financing in excess of $20,000,000.
The
Convertible Notes provide that in the event of the receipt by the Company or any
of its subsidiaries of any proceeds from any “Asset Sale” or
“Insurance/Condemnation Award”, the Company shall apply within thirty
(30) Business Day after the receipt thereof the net after-tax proceeds
therefrom to pay in cash the principal and all accrued but unpaid interest
hereunder. “Asset Sale” means any sale, transfer, conveyance or other
disposition by the Company or any of its subsidiaries of any of its property or
assets, other than the sale of inventory in the ordinary course of business.
“Insurance/Condemnation Award” means the receipt by the Company or any of its
subsidiaries of any proceeds received under any casualty insurance polity
maintained by or for the benefit of the Company or any of its subsidiaries or as
a result of the taking of any assets of the Company or any of its subsidiaries
pursuant to the power of eminent domain or condemnation.
LOANS
FROM FINANCIAL INSTITUTIONS
GAIA has
two loans from financial institutions, which totaled $_99,000_ and $104,000 as
of September 30, 2008 and December 31, 2007, respectively, that are
collateralized by the assets of the Company and bear European commercial
standard rates.
SILENT
PARTNERSHIP LOANS-NON-RELATED PARTIES
Technology-Beteiligungs-Gesellschaft
GmbH der Deutschen Ausgleichsbank (“TBG”) has provided a partnership loan, which
bears interest at 6% per annum. The total amount payable to TBG under the
Partnership Agreements at September 30, 2008 and December 31, 2007 was
$2,216,000 and $2,259,000, respectively. TBG is entitled to receive
an annual 12% share in profits related to its contributions under the TBG
Partnership Agreement. The TBG Partnership Agreement provides that
should GAIA receive additional injections of capital in the course of further
financing rounds, TBG shall adjust its profit sharing to the capital ration
applicable at such time. Management believes that based upon subsequent equity
received by GAIA that the present profit sharing that TBG is entitled to under
the Agreement is approximately 4.4 %. Management further believes that it is
unlikely that TBG will receive any profit sharing under the Partnership
Agreement at any time in the near future.
From
March 8, 2005 under the TBG Partnership Agreement, TBG is entitled to
demand a non-recurrent remuneration of 30% of the amount invested plus 6% of the
amount invested at the end of the period of participation for each year after
the expiration of the fifth full year of participation under certain
circumstances relating to the economic condition of GAIA. The TBG Partnership
Agreement terminates in December 2008, unless terminated prior to such time for
good cause as defined in the applicable partnership agreement.
The
principal, accrued and unpaid interest, and unpaid profits, if any are due on
the termination of the TBG Partnership Agreement.
SUBORDINATED
LOANS FROM RELATED PARTY
GAIA has
received subordinated loans from Arch Hill, a related party, which totaled
$5,254,000 and $6,272,000 as of September 30, 2008 and December 31,
2007. The loans bear cumulative interest at 6% per annum. Under the
subordinated loan agreement (the “Subordinated Loan Agreement”) terms, the loans
can be called when GAIA does not have negative stockholders’ equity. The loans
are subordinated to all other creditors of GAIA.
On
February 28, 2008, the Company and GAIA executed a Debt Settlement
Agreement with Arch Hill Ventures N.V., Arch Hill Real Estate N.V. and Arch Hill
Capital N.V. (collectively, the “Debtholders”). Pursuant to the Agreement
$5,773,707 of debt owed by LTC and GAIA to the Debtholders was settled. LTC
agreed to issue to Arch Hill Capital N.V. 302,714,400 shares of LTC common stock
in full and complete settlement of the Debt (the “Debt Settlement”). In the
Agreement, Arch Hill Capital agreed that for a two year period it will not,
directly or indirectly, without the prior written consent of LTC issue, offer,
agree or offer to sell, sell, grant an option for the purchase or sale of,
transfer, pledge, assign, hypothecate, distribute or otherwise encumber or
dispose of the Shares.
As
described above, the Company agreed to issue 302,714,400 common stock shares,
but because the Company did not have enough shares of common stock authorized,
the Company issued 45,016.84 Series C Preferred Stock in lieu of issuing
112,542,100 for partial debt settlement.
The
Company and Arch Hill, which is approximately 64% beneficial owner of the
Company, settled $2,146,529 of Arch Hill’s outstanding debt by issuing 45,016.84
shares of Series C Preferred Stock. Because this is a related party transaction,
any losses on settlement would be recorded as an adjustment to equity with no
financial statement impact. The Company recorded the Series C Preferred Stock
issued at par value with the difference affecting additional paid in capital for
a total impact on equity of $2,146,529.
As Arch
Hill received a beneficial conversion price on the Series C Preferred Stock, a
beneficial conversion feature was recorded on the Series C. Per paragraph 5 of
EITF 98-5, the embedded beneficial conversion feature was recognized by
allocating a portion of the proceeds equal to intrinsic value of the feature to
additional paid in capital.
Per
paragraph 6 of EITF 98-5 the amount allocated to the beneficial conversion
feature is limited to the amount of the proceeds allocated to the convertible
instrument. As such, in this case, the amount of the beneficial conversion
feature was limited to $2,146,529.
Series C
Preferred Stock is convertible upon the Company’s authorization and upon the
Company having a sufficient number of shares of common stock available for
issuance. Although the Company has to approve any notice of conversion, the
holder can submit a conversion option at time of issuance of the stock. As such,
management believes it is appropriate to record the beneficial conversion
discount at time of issuance of the Series C Preferred Stock.
As the
Company has accumulated deficit and no retained earnings, the beneficial
conversion will be recorded as follows: debit and credit to additional paid in
capital for $2,146,529. The transaction will be shown as separate line item in
the statement of stockholders’ deficit and is reflected on the income statement
as a decrease of income applicable to common shareholders. The above accounting
is consistent with the Minutes of joint session with SEC of AICPA SEC regulation
Committee which took place on March 20, 2001.
The
balance of $3,627,179 remains payable to Arch Hill after issuance of the Series
C Preferred Stock, and is included in the Promissory Notes balance account
detailed below. As the conversion price is beneficial to Arch Hill at the time
of the settlement agreement because the conversion price was below market on
that date, a beneficial conversion discount was recorded on the remaining
debt.
Based on
management’s calculations, the beneficial conversion discount was higher than
the value of the remaining note payable. As the beneficial conversion discount
cannot exceed the face value of the note, it was capped at $3,627,179. Since the
debt has no redemption date subsequent to the settlement agreement, the
beneficial conversion discount was expensed immediately at the time of the debt
settlement transaction.
NOTE
9—COMMITMENTS AND CONTINGENCIES
BUILDING
LEASE
The
Company was leasing a 12,400 square foot facility at 5115 Campus Drive in
Plymouth Meeting, Pennsylvania pursuant to a Lease Agreement with PMP Whitemarsh
Associates dated July 22, 1994, as amended. The facility was being leased
under a one-year lease extension that commenced on April 1, 2008 and ended
on March 31, 2009. The base annual rent under this lease agreement was
$160,000. LTC did not extend the lease after March 31, 2009. In August 2008 the
Company signed an Asset Purchase Agreement with Porous Power Technologies and a
Sublease Agreement with Porous Power Technologies. At the facility, the Company
sold some of the assets to Porous Power Technologies, the others which could be
of use to the Company at its manufacturing facility in Nordhausen, Germany were
shipped from Plymouth Meeting to Nordhausen, Germany. Porous Power Technologies
has been sub-tenant to the Company at the Company’s Plymouth Meeting facility
from August 2008 until March 31, 2009. Porous Power Technologies signed a lease
agreement for the Plymouth Meeting facility on April 1, 2009. The Company signed
a six month sublease agreement on April 1, 2009 with Porous Power Technologies
of a total rent of $42,000 ($7,000 per month), with the possibility to extend
the sublease for 3 month periods. This facility has sufficient space to meet the
Company’s near-term needs in the United States. The Company’s
corporate headquarters are located at the Plymouth Meeting, Pennsylvania
facility.
LITIGATION
The
Company entered into a Financial Advisory and Investment Banking Agreement with
North Coast Securities Corporation (“North Coast”) dated February 1, 2006.
Subsequent to the date of the Agreement North Coast asserted claims for unpaid
compensation under the Agreement. Counsel for North Coast have asserted a breach
of contract claim against the Company seeking warrants to purchase 500,000
shares of Company common stock with an exercise price of $0.04 per share and
$10,000 per month for the term of the Agreement for a total of $120,000. On
December 31, 2007 a lawsuit was filed in Montgomery County against the
Company in this matter. Management asserts that no services were rendered to
satisfy any compensation. The Court has dismissed the case with prejudice.on
March 30th, 2009.
The Company was responsible for its own legal fees in this matter.
Andrew J.
Manning, a former employee of the Company, filed a complaint in October 2008, in
the Superior Court of New Jersey, Morris County, Law Division, against the
Company and other parties, alleging breach of contract, breach of covenant of
good faith and fair dealing, negligent misrepresentation, tortious interference
with Mr. Manning’s economic gain, retaliation, unjust enrichment, and
intentional infliction of emotional distress. The Company and management believe
that the allegations in the Complaint have no merit and the Company intends to
vigorously defend the suit. This matter has not been resolved as of the date
hereof.
From time
to time the Company is a defendant or plaintiff in various legal actions which
arise in the normal course of business. As such the Company is required to
assess the likelihood of any adverse outcomes to these matters as well as
potential ranges of probable losses. A determination of the amount of the
provision required for these commitments and contingencies, if any, which would
be charged to earnings, is made after careful analysis of each matter. The
provision may change in the future due to new developments or changes in
circumstances. Changes in the provision could increase or decrease the Company’s
earnings in the period the changes are made. In the opinion of management, after
consultation with legal counsel, the ultimate resolution of these matters will
not have a material adverse effect on the Company’s financial condition, results
of operations or cash flows.
NOTE
10—STOCKHOLDER’S EQUITY
AUTHORIZED
SHARES
The
Company is authorized to issue 750 million shares of the common stock and
100 million shares of preferred stock. Of the 100 million authorized
shares of preferred stock, the Company designated 1,000 shares as Series A
Convertible Preferred Stock, which the Company delivered to an investor in the
private placement of A Units which concluded in January 2005 and have
subsequently been converted into the Company’s common stock. Additionally, the
Company designated 100,000 shares of Series B Convertible Preferred Stock which
the Company delivered to Arch Hill Capital in connection with a debt exchange in
October 2005 which are outstanding as of September 30, 2008 and
December 31, 2007. Additionally, the Company designated 300,000 shares of
Series C Convertible Preferred. As of September 30, 2008 and
December 31, 2007, 263,200 and 218,183 shares of Series C were outstanding,
respectively.
SERIES
B PREFERRED STOCK
The
Company has authorized and outstanding 100,000 shares of Series B Convertible
Preferred Stock, which were issued on November 14, 2005. The shares of
Series B Convertible Preferred Stock are not entitled to receive dividends in
shares of the Company’s common stock. The 100,000 shares of convertible
preferred stock are convertible into an aggregate of 264,103,114 shares of
common stock and have voting rights equal to 264,103,114 shares of common
stock.
The
Series B Convertible Preferred Stock has no mandatory or optional redemption
rights, thus, cannot be redeemed for cash. The Series B Convertible Preferred
Stock is only convertible into the Company’s common stock upon the Company’s
approval and upon the Company having enough shares of common stock authorized to
issue. As the control of the conversion lies with the Company, the holder cannot
force conversion, and the stock has no redemption rights, the Series B Preferred
Stock is classified in permanent equity on the Company’s consolidated balance
sheet.
SERIES
C CONVERTIBLE PREFERRED STOCK
The
Company designated 300,000 of the Company’s authorized preferred stock as Series
C Preferred Stock in November 2006.
During
the first two quarters of 2008, the Company and Arch Hill, which is
approximately 64% beneficial owner of the Company, settled $2,146,529 of Arch
Hill’s outstanding debt by issuing 45,016.18 shares of Series C Preferred
Stock.
Each
share of the Series C Preferred Stock is convertible at the option of the
Company thereof into 2,500 shares of Company common stock at any time following
the authorization and reservation of a sufficient number of shares of Company
common stock by all requisite action, including action by the Company’s Board of
Directors and by Company stockholders, to provide for the conversion of all
outstanding shares of Series C Preferred Stock into shares of Company common
stock.
Each
share of the Series C Preferred Stock will automatically be converted into 2,500
shares of Company common stock 90 days following the authorization and
reservation of a sufficient number of shares of Company common stock to provide
for the conversion of all outstanding shares of Series C Preferred Stock into
shares of Company common stock.
The
shares of Series C Preferred Stock are entitled to vote together with the common
stock on all matters submitted to a vote of the holders of the common stock. On
all matters as to which shares of common stock or shares of Series C Preferred
Stock are entitled to vote or consent, each share of Series C Preferred Stock is
entitled to the number of votes (rounded up to the nearest whole number) that
the common stock into which it is convertible would have if such Series C
Preferred Stock had been so converted into common stock as of the record date
established for determining holders entitled to vote, or if no such record date
is established, as of the time of any vote on such matters. Each share of Series
C Preferred Stock is entitled to the number of votes that 2,500 shares of common
stock would have.
In
addition to the voting rights provided above, as long as any shares of Series C
Preferred Stock are outstanding, the affirmative vote or consent of the holders
of two-thirds of the then-outstanding shares of Series C Preferred Stock, voting
as a separate class, will be required in order for the Company to:
|
(i)
|
amend,
alter or repeal, whether by merger, consolidation or otherwise, the terms
of the Series C Preferred Stock or any other provision of Company Charter
or Bylaws, in any way that adversely affects any of the powers,
designations, preferences and relative, participating, optional and other
special rights of the Series C Preferred
Stock;
|
|
(ii)
|
issue
any shares of capital stock ranking prior or superior to, or on parity
with, the Series C Preferred Stock;
or
|
|
(iii)
|
subdivide
or otherwise change shares of Series C Preferred Stock into a different
number of shares whether in a merger, consolidation, combination,
recapitalization, reorganization or
otherwise.
|
The
Series C Preferred Stock ranks on a parity with the common stock as to any
dividends, distributions or upon liquidation, dissolution or winding up, in an
amount per share equal to the amount per share that the shares of common stock
into which such Series C Preferred Stock are convertible would have been
entitled to receive if such Series C Preferred Stock had been so converted into
common stock prior to such distribution.
The
Series C Preferred Stock has no mandatory or optional redemption rights, thus,
cannot be redeemed for cash. The Series C Preferred Stock is only convertible
into the Company’s common stock upon the Company’s approval and upon the Company
having enough shares of common stock authorized to issue. As the control of the
conversion lies with the Company, the holder cannot force conversion, and the
stock has no redemption rights, the Series C Preferred Stock is classified in
permanent equity on the Company’s consolidated balance sheet. Upon issuance of
the Series C Convertible Preferred stock the par value ($0.01) is credited
toward the preferred share class C, and the balance is credited toward
additional paid-in capital. For issuances of convertible Preferred Stock with
beneficial conversion feature the discount is recognized upon issuance as a
debit and a credit to additional paid in capital. The beneficial conversion
discount on the Series C Preferred Stock is shown as separate line item in the
statement of stockholders’ deficit and is reflected on the income statement as a
decrease/ increase of income/loss applicable to common
shareholders.
NOTE
11—SEGMENT INFORMATION
SFAS
No. 131, “Disclosure About Segments of an Enterprise and Related
Information” (SFAS 131), defines operating segments as components of an
enterprise for which separate financial information is available that is
evaluated regularly by the chief operating decision maker in deciding how to
allocate resources and in assessing performance. Based on the way it organizes
its business for making operating decisions and assessing performance, the
Company has determined that it has two geographical separable reportable
operating segments.
Management
reviews its Domestic Operations and its European Operations to evaluate
performance and resources. Management has aggregated its operations into one
industry segment since its Domestic and European Operations are similar and meet
the aggregation criteria of SFAS 131, “Disclosures about segments of an
enterprise and related information”.
Geographic
information is as follows:
|
|
Nine
Months Ended
|
|
|
Nine
Months Ended
|
|
|
|
September
30, 2008
|
|
|
September
30, 2007
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic
Operations
|
|
$ |
1,115,000 |
|
|
|
31 |
% |
|
$ |
1,401,000 |
|
|
|
69 |
% |
European
Operations
|
|
$ |
2,487,000 |
|
|
|
69 |
% |
|
$ |
623,000 |
|
|
|
31 |
% |
|
|
$ |
3,602,000 |
|
|
|
|
|
|
$ |
2,024,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-lived
assets, net
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Domestic
Operations
|
|
$ |
90,000 |
|
|
|
1 |
% |
|
$ |
124,000 |
|
|
|
2 |
% |
European
Operations
|
|
$ |
7,380,000 |
|
|
|
99 |
% |
|
$ |
5,882,000 |
|
|
|
98 |
% |
|
|
$ |
7,470,000 |
|
|
|
|
|
|
$ |
6,006,000 |
|
|
|
|
|
NOTE
12—NET INCOME/LOSS PER COMMON SHARE
The
Company has presented net loss per common share pursuant to SFAS No. 128,
“Earnings Per Share”. Net loss per common share is based upon the weighted
average number of outstanding common shares. The Company has determined that the
as-if converted common shares related to the preferred shares should be included
in the weighted average shares outstanding for purposes of calculating basic
earnings per share. The Company made such determination because: 1) Arch Hill
Capital, which controls the Company and some of the preferred shares, has the
ability to authorize the necessary shares for conversion; 2) the preferred
shares have no significant preferential rights above the common shares; and 3)
the preferred shares will automatically convert at a later date upon proper
share authorization. As a result, weighted average shares outstanding included
in the calculation of basic and diluted net loss per common share for the nine
and three months ended September 30, 2008 and 2007 was as
follows:
|
|
Nine
Months Ended
|
|
|
Nine
Months Ended
|
|
|
Three
Months Ended
|
|
|
Three
Months Ended
|
|
|
|
September
30, 2008
|
|
|
September
30, 2007
|
|
|
September
30, 2008
|
|
|
September
30, 2007
|
|
Series
B Preferred Stock
|
|
|
264,103,114 |
|
|
|
264,103,114 |
|
|
|
264,103,114 |
|
|
|
264,103,114 |
|
Series
C Preferred Stock
|
|
|
658,000,000 |
|
|
|
258,388,769 |
|
|
|
658,000,000 |
|
|
|
258,388,769 |
|
Common
Stock
|
|
|
670,924,782 |
|
|
|
422,994,852 |
|
|
|
670,924,782 |
|
|
|
422,994,852 |
|
Total
|
|
|
1,593,027,896 |
|
|
|
945,486,735 |
|
|
|
1,593,027,896 |
|
|
|
945,486,735 |
|
Due to
net losses in all periods ended September 30, 2008 and 2007, the effect of
the potential common shares resulting from convertible promissory notes payable,
stock options and warrants were excluded, as the effect would have been
anti-dilutive. As of September 30, 2008 there are 67,437,199 warrants
outstanding with a weighted average exercise of $0.552.
The
Company does not have enough shares of common stock authorized to issue shares
of common stock to all holders of its convertible securities upon conversion of
such securities. The Company intends to seek stockholder approval of an increase
in the authorized number of shares of its common stock to make available that
number of shares of common stock as will be required for the conversion of all
of the Company’s outstanding convertible securities and securities which may be
issued as part of a new financing. Although the Company’s controlling
stockholder has indicated its willingness to vote in favor of an increase in the
authorized number of shares of Company common stock, no assurance can be given
that the Company will be able to obtain a stockholder vote in favor of such an
increase in a timely manner.
NOTE
13—CORPORATE MATTERS
Governance
Agreement
On
April 28, 2008 the Company entered into a Governance Agreement (the
“Governance Agreement”) with certain shareholders of the Company (the
“Investors”), Stichting Gemeenschappelijk Bezit LTC, (the “Foundation”), and
Arch Hill Capital NV (“Arch Hill Capital” and together with the Foundation, the
“Arch Hill Parties”). The Investors include eight persons or entities that are
the beneficial owners of shares of the Company’s Series C Preferred Stock and/or
Common Stock. The Investors beneficially own approximately 29% of the Company’s
Common Stock in the aggregate. Arch Hill Capital beneficially owns approximately
64% of the Company’s Common Stock including the shares beneficially owned by its
affiliate the Foundation.
The
Company, the Foundation, Arch Hill Capital and the Investors have determined
that it is the best interest of the Company and its shareholders to enter into
certain governance and other arrangements with respect to the Company on the
terms set forth in the Governance Agreement. The Governance Agreement provides
that as of the Effective Time Ralph D. Ketchum, Marnix Snijder and Clemens E.M.
van Nispen tot Sevenaer, directors of the Company, resign as directors of the
Company (the “Resigning Directors”) and that the number of directors of the
Company be set at six. The Governance Agreement further provides that Fred J.
Mulder and Theo M.M. Kremers be appointed directors of the Company as of the
Effective Time to fill the vacancies on the Board of Directors resulting from
the resignation of the Resigning Directors.
Consulting
Agreements
In
connection with the Governance Agreement, on April 28, 2008 the Company
entered into a consulting agreements with each of Christiaan A. van den Berg
(the “Van Den Berg Consulting Agreement”), Fred J. Mulder (the “Mulder
Consulting Agreement”), OUIDA Management Consultancy B.V. (the “OUIDA Consulting
Agreement”), and Romule B.V. (the “Romule Consulting Agreement”) (collectively,
the “Consulting Agreements”).
Each of
the Consulting Agreements has a term of one year and may be terminated on 60
days written notice. Each Consulting Agreement provides that the Consultant will
consult with the directors, officers and employees of the Company concerning
matters relating to the management and organization of the Company, its
financial policies, the terms and conditions of employment of the Company’s
employees, and generally any matter arising out of the business affairs of the
Company.
The
Mulder Consulting Agreement with Fred J. Mulder, a newly appointed director of
the Company, provides for Mr. Mulder to spend approximately 32 hours per
month in fulfilling his obligations under the Consulting Agreement and the
payment by the Company of a monthly fee of U.S. $4,167.
The Van
Den Berg Consulting Agreement with Christiaan A. van den Berg, the Chief
Executive of Arch Hill Capital and the Foundation and the co-chairman of the
Board of the Company, provides for Mr. van den Berg to spend approximately
32 hours per month in fulfilling his obligations under the Consulting Agreement
and the payment by the Company of a monthly fee of US $4,167.
The
Romule Consulting Agreement provides for Frits Obers, an employee of Romule
B.V., to spend approximately 160 hours per month in fulfilling his obligations
under the Consulting Agreement and the payment by the Company of a monthly fee
of Euros 20,820 (approximately US $30,000 as of the date of the
agreement).
The OUIDA
Consulting Agreement provides for Theo Kremers, an employee of OUIDA Management
Consultancy B.V. and a newly appointed director of the Company, to spend
approximately 160 hours per month in fulfilling his obligations under the
Consulting Agreement and the payment by the Company of a monthly fee of Euros
20,820 (approximately US $30,000 as of the date of the agreement).
Appointment of Chief
Executive Officer
Effective
June 27, 2008, Theo M. M. Kremers was appointed as the Chief Executive
Officer of Lithium Technology Corporation by the Company’s Board of Directors.
Prior to this Mr. Kremers had been serving as a Director of the Company
since May 27, 2008. Mr. Kremers’ company, OUIDA Management Consultancy
B.V. was retained by the Company in April 28 2008 to provide consulting
services. Mr. Kremers is paid a monthly fee of Euros 20,820 (approximately
US $30,000 as of the date of the agreement) for his services to the
Company.
NOTE
14—SUBSEQUENT EVENTS
Resignation of Chief
Financial Officer
Effective
October 15, 2008, Amir Elbaz resigned as the Chief Financial Officer of the
Company. Mr. Elbaz continued working with the Company during a transition
period up to November 30, 2008.
June 2008 9% Convertible
Notes
The
Company closed on additional debt financings under the June 2008 Financing
described herein (see Note 8) with seven institutional investors from October 6,
2008 to November 12, 2008 for a total of Euros 1,263,100
(approximately U.S. $1,644,665).
Advisor to Board
Appointed
As of December 1, 2008, Mr. Ben van Schaik has been
appointed as an Advisor to the Board of Directors of the Company. Mr.
van Schaik has been asked to serve as an Advisor on account of his long standing
experience in the automotive sector, as well as his extensive network within the
industry. Mr. van Schaik will be paid €15,000 per year for his
services.
Increase in Authorized
Shares of Common Stock
On March 25, 2009, the Company filed an Amendment to its
Restated Certificate of Incorporation with the Secretary of State of the State
of Delaware, to increase the number of authorized shares of the Company’s common
stock to 3,000,000,000 shares (the “Authorization Date”). The
amendment of the Company’s Restated Certificate of Incorporation to reflect the
increase was approved by the Company’s Board of Directors and the holders of a
majority of the Company’s common stock in October 2008. An
information statement describing the amendment was mailed to stockholders on
February 10, 2009 and became effective on March 2, 2009. The increase
in the number of authorized shares of common stock is needed in order for the
Company to have an adequate reserve of common stock available for issuance upon
conversion of existing convertible securities and exercise of outstanding
options and warrants and to satisfy certain commitments to issue common
stock.
The terms of the Company’s Series C Preferred Stock
provide for the automatic conversion of each outstanding share of Series C
Preferred Stock into 2,500 shares of Company common stock ninety (90) days
following authorization and reservation of a sufficient number of shares of
Common Stock by all requisite action by the Corporation, including action by the
Board and by the shareholders of the Corporation, to provide for the conversion
of all outstanding shares of Series C Preferred into fully paid and
nonassessable shares of Common Stock. Accordingly, all shares of
Series C Preferred Stock outstanding on June 23, 2009, ninety (90) days of the
Authorization Date, will be converted into shares of common
stock.
|
MANAGEMENT’S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
|
The
following discussion and analysis should be read together with the financial
statements and the accompanying notes thereto included elsewhere in this
Report.
The
Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for
forward-looking statements. This report contains certain forward-looking
statements and information that are based on the beliefs of management as well
as assumptions made by and information currently available to management. The
statements contained in this Report relating to matters that are not historical
facts are forward-looking statements that involve risks and uncertainties,
including, but not limited to, the successful commercialization of our
batteries, future demand for our products, general economic conditions,
government and environmental regulation, competition and customer strategies,
technological innovations in the battery industries, changes in our business
strategy or development plans, capital deployment, business disruptions, our
ability to consummate future financings and other risks and uncertainties,
certain of which are beyond our control. Additional factors that could affect
the Company’s forward-looking statements include, among other things: the
restatement of the Company’s financial statements for the fiscal year ended
December 31, 2004, and the delay in filing financial statements and
periodic reports with the Securities and Exchange Commission for the fiscal
years ended December 31, 2005, December 31, 2006,
December 31, 2007 and December 31, 2008; negative reactions from the
Company’s stockholders, creditors, customer or employees to the results of the
review and restatement or delay in providing financial information and periodic
reports; the impact and result of any litigation (including private litigation),
or of any investigation by the Securities and Exchange Commission or any
investigation by any other governmental agency related to the Company; the
Company’s ability to manage its operations during and after the financial
statement restatement process; and the Company’s ability to successfully
implement internal controls and procedures that remediate any material weakness
in controls and ensure timely, effective and accurate financial reporting.
Should one or more of these risks or uncertainties materialize, or should
underlying assumptions prove incorrect, actual results may differ materially
from those described herein as anticipated, believed, estimated or
expected.
Forward-looking
statements are based on management’s current views and assumptions and involve
known and unknown risks that could cause actual results, performance or events
to differ materially from those expressed or implied in those
statements.
GENERAL
We are
engaged in continuing contract development and limited volume production, in
both the United States and Germany, of large format lithium-ion rechargeable
batteries used as power sources in advanced applications in the national
security, transportation and stationary power markets. We have moved from a
development and pilot-line production company to a small production business
with our lithium-ion rechargeable batteries.
RESULTS
OF OPERATIONS
NINE
AND THREE MONTHS ENDED SEPTEMBER 30, 2008 COMPARED TO
NINE
AND THREE MONTHS ENDED SEPTEMBER 30, 2007
REVENUES FROM PRODUCTS SALES
Increased by $1,578,000 or 78% in the nine months ended
September 30, 2008 from $2,602,000 in the same period in 2007 to
$3,602,000. For the three months period ended September 30, 2008, revenues
increased 55% from $8431,000 in 2007 to $1,306,000 in 2008. The increase in
sales is attributed to increased sales efforts and fruition of some projects the
Company is involved with. As we are still an initial manufacturing stage
enterprise, our mission continues to be to become a leading manufacturer of
rechargeable lithium power solutions for advanced national security,
transportation and stationary power applications.
COST OF GOODS SOLD was
$6,443,000 and $2,602,000 for the nine months ended September 30, 2008 and
2007, respectively. For the three months period ended September 30, 2008,
cost of goods sold increased 207% from $1,034,000 in 2007 to $3,175,000 in 2008.
The increase in the cost of goods sold is a result of production changes. We
continue to look for cheaper sources of raw materials and more efficient
production processes. We anticipate costs to decline substantially as we achieve
larger economies of scale.
ENGINEERING, RESEARCH AND DEVELOPMENT
EXPENSES during the nine months ended September 30, 2008 decreased
by 40% to $1,394,000 from $2,320,000 in the same period in 2007. For the three
months period ended September 30, 2008, engineering, research and
development expenses decreased from $690,000 in 2007 to $0 in 2008. These
expenses are primarily derived from our advancement of technology in large high
rate battery applications. These expenses relate to material consumed in the
continued refinement of production process, as well as engineering and
development time dedicated to advancement of manufacturing processes as well as
time associated with the installation of new production equipment.
GENERAL AND ADMINISTRATIVE
EXPENSES during the nine months ended September 30, 2008 increased
by 37% to $5,401,000 from $2,320,000 in the same period in 2007. This increase
reflects our efforts to move to larger scale manufacturing, hiring of
professional consultants, and increased financing related efforts and costs. For
the three months period ended September 30, 2008, general and
administrative expenses increased 103% from $1,130,000 in 2007 to $2,297,000 in
2008.
SALES AND MARKETING EXPENSES
were $537,000 for the nine months ended September 30, 2008, an increase of
69% from the same period in 2007. For the three months period ended
September 30, 2008, sales and marketing expenses decreased from $236,000 in
2007 to $0 in 2008. The decrease in this expense is attributed to
reclassifications of costs to Cost of Goods Sold.
DEPRECIATION AND AMORTIZATION
during the nine months ended September 30, 2008 decreased by 52% to
$331,000 from $693,000 in the same period in 2007. For the three months period
ended September 30, 2008, depreciation and amortization expenses decreased
32% from $114,000 in 2007 to $0 in 2008. The decrease in this expense is
attributed to reclassifications of costs to Cost of Goods Sold.
INTEREST EXPENSE, NET OF INTEREST
INCOME Interest expense, net of interest income for the nine months ended
September 30, 2008 decreased by 63% to $580,000 from $1,5886,000 in the
same period in 2007. For the three months period ended September 30, 2008,
interest expense increased from $252,000 in 2007 to $370,000 in
2008.
INTEREST EXPENSE RELATED TO
BENEFICIAL CONVERSION Charge for beneficial conversion feature was
$3,827,000 and $1,633,000, respectively, in the nine months ended
September 30, 2008 and 2007. For the three months period ended
September 30, 2008, interest expense related to beneficial conversion
decreased to $55,000 in 2008 from $58,000 in the same period in 2007. For more
information concerning this, please refer to the Notes to Financial Statement
contained herein.
WARRANTS EXPENSE Charges for
warrants were $(12,173,000) and $16,242,000 respectively, in the nine months
period ended September 30, 2008 and 2007. For the three months period ended
September 30, 2008, warrants expenses decreased $875,000 in 2007 to
$(3,750,,000) in 2008. Warrants valuation is marked to market every reporting
period using Black-Scholes valuation model. Fluctuations resulting from the
valuation of the warrants’ liability are reflected in the Statement of
Operations. Approximately $2.6 million of the gain recorded in the Statement of
Operations for the nine months period ended September 30, 2008 resulted
from revaluation of Yorkville Advisors (f/k/a/Cornell Capital) warrants
immediately prior to the exercise.
NET (LOSS) TO COMMON
SHAREHOLDERS $(2,087,,000) or $(0.00) per share for the nine months ended
September 30, 2008 as compared to a net loss of $(38,652,,000) or $(0.03)
per share for the nine months ended September 30, 2007.
ACCUMULATED DEFICIT Since
inception, we have incurred substantial operating losses and expect to incur
substantial additional operating losses over the next few years. As of
September 30, 2008, our accumulated deficit was $133,898,000.
LIQUIDITY
AND FINANCIAL CONDITION
GENERAL
On
September 30, 2008, cash and cash equivalents were $296000. Total
liabilities on September 30, 2008 were $20,412,000 consisting of all
current liabilities. On September 30, 2008, assets included $32.326,000 in
inventories, net property and equipment of $8,399,000, and prepaid expenses and
other assets of $409,000. As of September 30, 2008, our working capital
deficit was $17,140,000 as compared to $25,444,000 on December 31, 2007. We
expect to incur decreasing operating losses as we continue our commercialization
efforts.
Our debt
and other liabilities as of September 30, 2008 and December 31, 2007
were as follows:
Debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30,
2008
|
|
|
December 31,
2007
|
|
Current debt is summarized as
follows:
|
|
|
|
|
|
|
Loans From Financial
Institutions
|
|
$ |
990,000 |
|
|
$ |
104,000 |
|
Silent Partner
loans-TBG
|
|
$ |
2,216,000 |
|
|
$ |
2,259,000 |
|
July 2007 10% Convertible
Debenture, net of discount
|
|
$ |
3,247,000 |
|
|
$ |
3,048,000 |
|
June 2008, 9% Convertible Note,
net of discount
|
|
$ |
3,776,000 |
|
|
|
|
|
Sub total current
debt
|
|
$ |
10,229,000 |
|
|
$ |
5,411,000 |
|
Related party
debt:
|
|
|
|
|
|
|
|
|
Subordinated Loans from
Archhill
|
|
$ |
1,627,000 |
|
|
$ |
6,272,000 |
|
Promissory Note to
Archhill
|
|
$ |
3,627,000 |
|
|
$ |
60,000 |
|
Sub total Related party
debt
|
|
$ |
5,254,000 |
|
|
$ |
6,332,000 |
|
Warrant
liability
|
|
$ |
890,000 |
|
|
$ |
15,550,000 |
|
Total current
debt
|
|
$ |
16,373,000 |
|
|
$ |
27,293,000 |
|
For more
detailed information on long-term liabilities, see Note 8 to our financial
statements contained herein.
FINANCING
TRANSACTIONS
We have
financed our operations since inception primarily through equity and debt
financings, loans from shareholders and other related parties, loans from silent
partners and bank borrowings secured by assets. We have recently entered into a
number of financing transactions and are continuing to seek other financing
initiatives. We will need to raise additional capital to meet our working
capital needs and to complete our product commercialization process. Such
capital is expected to come from the sale of securities. No assurances can be
given that such financing will be available in sufficient amounts or at all. If
such financing is not available there can be no assurance that Arch Hill Capital
or any other major shareholder will provide any further funding.
The
following is a general description of our financing transactions through
September 30, 2008. See also the Notes to Consolidated Financial Statements
included with this Report.
JULY
2007 10% CONVERTIBLE DEBENTURE
On
July 11, 2007, the European Subsidiaries Debt and accrued interest was
satisfied with the payment of €6 million and the issuance of a Company
convertible note in the principal amount of U.S. $3,247,106 (the “Convertible
Note”). The Convertible Note is convertible into shares of Company common stock
at $0.10 per share. The Convertible Note accrues interest at 10% per annum
and is due and payable on September 1, 2008. The Company has the right to
repay the Convertible Note at any time prior to maturity without penalty. The
Convertible Note will be secured by 90 million shares of Company common
stock. The Company did not pay any underwriting discounts or commissions in
connection with the issuance of the Convertible Note in this transaction.
Issuance of the Convertible Note was exempt from registration under
Section 4(2) of the Securities Act. The Convertible Note was issued to an
accredited investor in a private transaction without the use of any form of
general solicitation or advertising. The underlying securities are “restricted
securities” subject to applicable limitations on resale. As of
September 30, 2008 and December 31, 2007, $3,193,000 and $3,048,000
was outstanding under the convertible debenture net of debt discount of $54,000
and $199,000, respectively. As of September 30, 2008 and December 31,
2007, accrued interest of $317,000, and $154,000, respectively, was outstanding
under the Convertible Note. Upon issuance, the Company recorded a discount from
beneficial conversion feature of $325,000 that is amortized over the life of the
note using the effective interest method.
JUNE
2008 9% CONVERTIBLE NOTES
The
Company closed on a convertible debt financing (the “June 2008 Financing”) with
four institutional investors from June 12, 2008 to September 30, 2008
for a total of Euros 2.60 million (approximately U.S. $5,757,000) including
57k€ (approximately U.S. $82,000) of accrued
interest and closed on additional June 2008 Financings
described herein with seven institutional investors from October 6, 2008 to
November 12, 2008 for a total of Euros 1,263,100 (approximately U.S.
$1,644,665). The Company issued its convertible notes (the “Convertible Notes”)
to the institutional investors (the “Lenders”) in connection with the June 2008
Financing. The Convertible Notes are convertible at $0.10 per share into Company
common stock or any equity securities issued by the Company after the date of
issuance of the Convertible Notes. The Convertible Notes accrue interest at
9% per annum and are due and payable on September 30, 2011 (the
“Maturity Date”). All obligations of the Company under the Convertible Notes
will be secured by security interests in all of the tangible and intangible
fixed assets, including real estate, of the Company.
Prior to
the Maturity Date, the Convertible Notes are due and payable within three months
of a “Change in Control” of the Company or a “Financing”. “Change in Control” of
the Company is defined to have occurred if, at any time following the date of
the Convertible Notes: (A) any “person” or “group” (as such terms are used
in Sections 3(a)(9) and 13(d)(3) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”)) (other than the shareholders of the Company
identified in (1) Amendment No. 16/6 to Schedule 13D filed with
respect to the Company on April 29, 2008 and (2) Schedule 13D
filed with respect to the Company on June 2, 2008) becomes a “beneficial
owner” (as such term is used in Rule 13d-3 promulgated under the Exchange Act),
directly or indirectly, of securities of the Company representing 50% or more of
the combined voting power of the Company’s then outstanding securities;
(B) a change in “control” of the Company (as the term “control” is defined
in Rule 12b-2 or any successor rule promulgated under the Exchange Act) shall
have occurred; (C) the shareholders or the Board of Directors of the
Company approve a plan of complete liquidation of the Company or an agreement
for the sale or disposition by the Company of all or substantially all of the
Company’s assets; or (D) the shareholders or the Board of Directors of the
Company approve a merger or consolidation of the Company with any other company,
other than a merger or consolidation which would result in the combined voting
power of the Company’s voting securities outstanding immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted
into voting securities of the surviving entity) more than 50% of the combined
voting power of the voting securities of the Company or such surviving entity
outstanding immediately after such merger or consolidation. “Financing” is
defined as the consummation by the Company or any of its subsidiaries of any
debt or equity financing in excess of $20,000,000.
The
Convertible Notes provide that in the event of the receipt by the Company or any
of its subsidiaries of any proceeds from any “Asset Sale” or
“Insurance/Condemnation Award”, the Company shall apply within thirty
(30) Business Day after the receipt thereof the net after-tax proceeds
therefrom to pay in cash the principal and all accrued but unpaid interest
hereunder. “Asset Sale” means any sale, transfer, conveyance or other
disposition by the Company or any of its subsidiaries of any of its property or
assets, other than the sale of inventory in the ordinary course of business.
“Insurance/Condemnation Award” means the receipt by the Company or any of its
subsidiaries of any proceeds received under any casualty insurance polity
maintained by or for the benefit of the Company or any of its subsidiaries or as
a result of the taking of any assets of the Company or any of its subsidiaries
pursuant to the power of eminent domain or condemnation.
LOANS
FROM FINANCIAL INSTITUTIONS
GAIA has
two loans from financial institutions, which totaled $99,000 and $104,000 as of
September 30, 2008 and December 31, 2007, respectively, that are
collateralized by the assets of the Company and bear European commercial
standard rates.
SILENT
PARTNERSHIP LOANS-NON-RELATED PARTIES
Technology-Beteiligungs-Gesellschaft
GmbH der Deutschen Ausgleichsbank (“TBG”) has provided a partnership loan, which
bears interest at 6% per annum. The total amount payable to TBG under the
Partnership Agreements at September 30, 2008 and December 31, 2007 was
$2,216,000 and $2,259,000, respectively. TBG is entitled to receive
an annual 12% share in profits related to its contributions under the TBG
Partnership Agreement. The TBG Partnership Agreement provides that
should GAIA receive additional injections of capital in the course of further
financing rounds, TBG shall adjust its profit sharing to the capital ration
applicable at such time. Management believes that based upon subsequent equity
received by GAIA that the present profit sharing that TBG is entitled to under
the Agreement is approximately 4.4 %. Management further believes that it is
unlikely that TBG will receive any profit sharing under the Partnership
Agreement at any time in the near future.
From
March 8, 2005 under the TBG Partnership Agreement, TBG is entitled to
demand a non-recurrent remuneration of 30% of the amount invested plus 6% of the
amount invested at the end of the period of participation for each year after
the expiration of the fifth full year of participation under certain
circumstances relating to the economic condition of GAIA. The TBG Partnership
Agreement terminates in December 2008, unless terminated prior to such time for
good cause as defined in the applicable partnership agreement.
The
principal, accrued and unpaid interest, and unpaid profits, if any are due on
the termination of the TBG Partnership Agreement.
SUBORDINATED
LOANS FROM RELATED PARTY
GAIA has
received subordinated loans from Arch Hill, a related party, which totaled
$5,254,000 and $6,272,000 as of September 30, 2008 and December 31,
2007. The loans bear cumulative interest at 6% per annum. Under the
subordinated loan agreement (the “Subordinated Loan Agreement”) terms, the loans
can be called when GAIA does not have negative stockholders’ equity. The loans
are subordinated to all other creditors of GAIA.
On
February 28, 2008, the Company and GAIA executed a Debt Settlement
Agreement with Arch Hill Ventures N.V., Arch Hill Real Estate N.V. and Arch Hill
Capital N.V. (collectively, the “Debtholders”). Pursuant to the Agreement
$5,773,707 of debt owed by LTC and GAIA to the Debtholders was settled. LTC
agreed to issue to Arch Hill Capital N.V. 302,714,400 shares of LTC common stock
in full and complete settlement of the Debt (the “Debt Settlement”). In the
Agreement, Arch Hill Capital agreed that for a two year period it will not,
directly or indirectly, without the prior written consent of LTC issue, offer,
agree or offer to sell, sell, grant an option for the purchase or sale of,
transfer, pledge, assign, hypothecate, distribute or otherwise encumber or
dispose of the Shares.
As
described above, the Company agreed to issue 302,714,400 common stock shares,
but because the Company did not have enough shares of common stock authorized,
the Company issued 45,016.84 Series C Preferred Stock in lieu of issuing
112,542,100 for partial debt settlement.
The
Company and Arch Hill, which is approximately 64% beneficial owner of the
Company, settled $2,146,529 of Arch Hill’s outstanding debt by issuing 45,016.84
shares of Series C Preferred Stock. Because this is a related party transaction,
any losses on settlement would be recorded as an adjustment to equity with no
financial statement impact. The Company recorded the Series C Preferred Stock
issued at par value with the difference affecting additional paid in capital for
a total impact on equity of $2,146,529.
As Arch
Hill received a beneficial conversion price on the Series C Preferred Stock, a
beneficial conversion feature was recorded on the Series C. Per paragraph 5 of
EITF 98-5, the embedded beneficial conversion feature was recognized by
allocating a portion of the proceeds equal to intrinsic value of the feature to
additional paid in capital.
Per
paragraph 6 of EITF 98-5 the amount allocated to the beneficial conversion
feature is limited to the amount of the proceeds allocated to the convertible
instrument. As such, in this case, the amount of the beneficial conversion
feature was limited to $2,146,529.
Series C
Preferred Stock is convertible upon the Company’s authorization and upon the
Company having a sufficient number of shares of common stock available for
issuance. Although the Company has to approve any notice of conversion, the
holder can submit a conversion option at time of issuance of the stock. As such,
management believes it is appropriate to record the beneficial conversion
discount at time of issuance of the Series C Preferred Stock.
As the
Company has accumulated deficit and no retained earnings, the beneficial
conversion will be recorded as follows: debit and credit to additional paid in
capital for $2,146,529. The transaction will be shown as separate line item in
the statement of stockholders’ deficit and is reflected on the income statement
as a decrease of income applicable to common shareholders. The above accounting
is consistent with the Minutes of joint session with SEC of AICPA SEC regulation
Committee which took place on March 20, 2001.
The
balance of $3,627,179 remains payable to Arch Hill after issuance of the Series
C Preferred Stock, and is included in the Promissory Notes balance account
detailed below. As the conversion price is beneficial to Arch Hill at the time
of the settlement agreement because the conversion price was below market on
that date, a beneficial conversion discount was recorded on the remaining
debt.
Based on
management’s calculations, the beneficial conversion discount was higher than
the value of the remaining note payable. As the beneficial conversion discount
cannot exceed the face value of the note, it was capped at $3,627,179. Since the
debt has no redemption date subsequent to the settlement agreement, the
beneficial conversion discount was expensed immediately at the time of the debt
settlement transaction.
SERIES
C CONVERTIBLE PREFERRED STOCK
During
the first quarter of 2008, the Company and Arch Hill, which is approximately 64%
beneficial owner of the Company, settled $2,146,529 of Arch Hill’s outstanding
debt by issuing 45,016.18 shares of Series C Preferred Stock.
Each
share of the Series C Preferred Stock is convertible at the option of the Holder
thereof into 2,500 shares of Company common stock at any time following the
authorization and reservation of a sufficient number of shares of Company common
stock by all requisite action, including action by the Company’s Board of
Directors and by Company stockholders, to provide for the conversion of all
outstanding shares of Series C Preferred Stock into shares of Company common
stock.
Each
share of the Series C Preferred Stock will automatically be converted into 2,500
shares of Company common stock 90 days following the authorization and
reservation of a sufficient number of shares of Company common stock to provide
for the conversion of all outstanding shares of Series C Preferred Stock into
shares of Company common stock.
The
shares of Series C Preferred Stock are entitled to vote together with the common
stock on all matters submitted to a vote of the holders of the common stock. On
all matters as to which shares of common stock or shares of Series C Preferred
Stock are entitled to vote or consent, each share of Series C Preferred Stock is
entitled to the number of votes (rounded up to the nearest whole number) that
the common stock into which it is convertible would have if such Series C
Preferred Stock had been so converted into common stock as of the record date
established for determining holders entitled to vote, or if no such record date
is established, as of the time of any vote on such matters.
In
addition to the voting rights provided above, as long as any shares of Series C
Preferred Stock are outstanding, the affirmative vote or consent of the holders
of two-thirds of the then-outstanding shares of Series C Preferred Stock, voting
as a separate class, will be required in order for the Company to:
|
(i)
|
amend,
alter or repeal, whether by merger, consolidation or otherwise, the terms
of the Series C Preferred Stock or any other provision of Company Charter
or Bylaws, in any way that adversely affects any of the powers,
designations, preferences and relative, participating, optional and other
special rights of the Series C Preferred
Stock;
|
|
(ii)
|
issue
any shares of capital stock ranking prior or superior to, or on parity
with, the Series C Preferred Stock;
or
|
|
(iii)
|
subdivide
or otherwise change shares of Series C Preferred Stock into a different
number of shares whether in a merger, consolidation, combination,
recapitalization, reorganization or
otherwise.
|
The
Series C Preferred Stock ranks on a parity with the common stock as to any
dividends, distributions or upon liquidation, dissolution or winding up, in an
amount per share equal to the amount per share that the shares of common stock
into which such Series C Preferred Stock are convertible would have been
entitled to receive if such Series C Preferred Stock had been so converted into
common stock prior to such distribution.
The
Series C Preferred Stock is deemed to be treated as equity since no redemption
option is present. Upon issuance of the Series C Convertible Preferred stock the
par value ($0.01) is credited toward the preferred share class C, and the
balance is credited toward additional paid-in capital. For issuances of
convertible Preferred Stock with beneficial conversion feature the discount is
recognized upon issuance.
MANAGEMENT’S
PLANS TO OVERCOME OPERATING AND
LIQUIDITY
DIFFICULTIES
Over the
past nine years, we have focused our unique extrusion-based large format
cylindrical cell manufacturing process, cell technology, large battery assembly
expertise, and market activities to concentrate on large-format, high rate
battery applications. Our commercialization efforts are focused on applying our
lithium-ion rechargeable batteries in the national security, transportation and
stationary power markets.
Our
operating plan seeks to minimize our capital requirements, but expansion of our
production capacity to meet increasing sales and refinement of our manufacturing
process and equipment will require additional capital. We expect that operating
and production expenses will increase significantly as we continue to ramp up
our production and continue our battery technology and develop, produce, sell
and license products for commercial applications.
Management
plans to use a more aggressive pricing structure through price reductions to be
able to address the market more aggressively in order to obtain larger volume
contracts. This price reduction will have an impact on the valuation of the
finished goods inventory which will be accounted for in the third quarter ended
September 30, 2008. All proposals sent out prior to the third quarter were
based on the Company’s pricing structure prior to any price
reductions.
We have
recently entered into a number of financing transactions (see Notes 8 and 10).
We are continuing to seek other financing initiatives. We need to raise
additional capital to meet our working capital needs, for the repayment of debt
and for capital expenditures. Such capital is expected to come from the sale of
securities and debt financing. We believe that if we raise approximately $14 to
$20 million in debt and equity financings, we would have sufficient funds to
meet our needs for working capital and expansion capital expenditures over the
next twelve months.
No
assurance can be given that we will be successful in completing any financings
at the minimum level necessary to fund our capital equipment, debt repayment or
working capital requirements, or at all. If we are unsuccessful in completing
these financings, we will not be able to meet our working capital, debt
repayment or capital equipment needs or execute our business plan. In such case
we will assess all available alternatives including a sale of our assets or
merger, the suspension of operations and possibly liquidation, auction,
bankruptcy, or other measures.
GOING
CONCERN MATTERS
Our
accompanying consolidated financial statements have been prepared on a going
concern basis, which contemplates the continuation of operations, realization of
assets and liquidation of liabilities in the ordinary course of business. Since
inception, we have incurred substantial operating losses and expect to incur
additional operating losses over the next several years. As of
September 30, 2008, we had an accumulated deficit of approximately
$132,881,000. We have financed our operations since inception primarily through
equity financings, loans from shareholders and other related parties, loans from
silent partners and bank borrowings secured by assets. We have recently entered
into a number of financing transactions and are continuing to seek other
financing initiatives. We will need to raise additional capital to meet our
working capital needs and to complete our product commercialization process.
Such capital is expected to come from the sale of securities and debt financing.
No assurances can be given that such financing will be available in sufficient
amounts or at all. Continuation of our operations in the future is dependent
upon obtaining such further financing. These conditions raise substantial doubt
about our ability to continue as a going concern. The accompanying consolidated
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.
CRITICAL
ACCOUNTING ESTIMATES
Our
discussion of results of operations and financial condition relies on our
condensed consolidated financial statements that are prepared based on certain
critical accounting estimates that require management to make judgments and
estimates that are subject to varying degrees of uncertainty. We believe that
investors need to be aware of these estimates and how they impact our financial
statements as a whole, as well as our related discussion and analysis presented
herein. While we believe that these accounting estimates are based on sound
measurement criteria, actual future events can and often do result in outcomes
that can be materially different from these estimates or forecasts.
The
critical accounting estimates and related risks described in our Annual Report
on Form 10-KSB for the fiscal year ended December 31, 2007 are those that
depend most heavily on these judgments and estimates. As of September 30,
2008, there have been no material changes to any of the critical accounting
estimates contained in our 2007 Annual Report on Form 10-KSB.
RISK
FACTORS AFFECTING OUR COMPANY
Investors
should carefully consider the following risk factors, in addition to the other
information concerning the factors affecting forward-looking statements. Each of
the risk factors could adversely affect business, operating results and
financial condition as well as adversely affect the value of an investment in
us.
WE ARE
SUBJECT TO VARIOUS RISKS THAT MAY MATERIALLY HARM OUR BUSINESS, FINANCIAL
CONDITION AND RESULTS OF OPERATIONS. IF ANY OF THESE RISKS OR UNCERTAINTIES
ACTUALLY OCCURS, OUR BUSINESS, FINANCIAL CONDITION OR OPERATING RESULTS COULD BE
MATERIALLY HARMED. IN THAT CASE, THE TRADING PRICE OF OUR COMMON STOCK COULD
DECLINE AND YOU COULD LOSE ALL OR PART OF YOUR INVESTMENT.
IN
ADDITION TO THE RISK FACTORS SET FORTH IN OUR FORM 10KSB FOR THE YEAR ENDED
DECEMBER 31, 2007, INVESTORS SHOULD BE AWARE OF THE FOLLOWING
RISKS:
|
•
|
|
WE
HAVE A WORKING CAPITAL LOSS, WHICH MEANS THAT OUR CURRENT ASSETS ON
SEPTEMBER 30, 2008 WERE NOT SUFFICIENT TO SATISFY OUR CURRENT LIABILITIES.
We had a working capital deficit of approximately $18,698,000 at
September 30, 2008, which means that our current liabilities exceeded
our current assets on September 30, 2008. Current assets are assets
that are expected to be converted to cash within one year and, therefore,
may be used to pay current liabilities as they become
due.
|
|
•
|
|
WE
HAVE SUBSTANTIAL INDEBTEDNESS AND ARE HIGHLY LEVERAGED. At
September 30, 2008, we had total consolidated current indebtedness of
approximately $23,838,000. The level of our indebtedness and related debt
service requirements could negatively impact our ability to obtain any
necessary financing in the future for working capital, capital
expenditures or other purposes. A substantial portion of our future cash
flow from operations, if any, may be dedicated to the payment of principal
and interest on our indebtedness. Our high leverage may also limit our
flexibility to react to changes in business and may place us at a
competitive disadvantage to less highly leveraged competitors. In
addition, creditors who remain unpaid may initiate collection proceedings,
which could hamper our operations due to our short-term cash needs or the
effect on our assets subject to
debt.
|
|
•
|
|
WE
HAVE A HISTORY OF OPERATING LOSSES AND HAVE BEEN UNPROFITABLE SINCE
INCEPTION. We incurred net losses of approximately $132,881,000 from
inception to September 30, 2008, including approximately $3,969,000
of loss to common shareholders in the quarter ended September 30,
2008. We expect to incur substantial additional operating losses in the
future. During the nine months ended September 30, 2008 and 2007, we
generated revenues from product sales in the amounts of $2,296,000 and
$1,181,000, respectively. We cannot assure you that we will continue to
generate revenues from operations or achieve profitability in the near
future or at all.
|
|
•
|
|
WE
NEED SIGNIFICANT FINANCING TO CONTINUE TO DEVELOP AND COMMERCIALIZE OUR
TECHNOLOGY. We have recently entered into a number of financing
transactions and are continuing to seek other financing initiatives. We
will need to raise additional capital to meet our working capital needs
and to complete our product commercialization process. Such capital is
expected to come from the sale of securities and debt financing. We
believe that if we raise approximately $14 to $20 million in debt and
equity financings, we would have sufficient funds to meet our operating
and expansion capital expenditures needs for at least twelve months. If we
do not raise such additional capital, we will assess all available
alternatives including a sale of our assets or merger, the suspension of
operations and possibly liquidation, auction, bankruptcy, or other
measures. Additional financing may not be available on terms favorable to
us or at all. Even if we do obtain financing, it may result in dilution to
our stockholders.
|
|
•
|
|
WE
FACE RISKS RELATED TO LATE SEC FILINGS. There was a delay in filing our
financial statements and periodic reports with the Securities and
Exchange Commission for the fiscal years ended December 31,
2005, December 31, 2006, December 31, 2007 and December 31,
2008. We have been working diligently with our auditors to
complete our filings in a timely manner. We have also engaged outside
expertise to assist us in this process. Nevertheless, the delay in the
completion of the audit of the year end financial statements and reviews
of the quarters’ financial statements may lead to litigation claims and/or
regulatory proceedings against us and may negatively impact our financing
efforts. This delay also impacted our ability to trade our shares on the
OTC Bulletin Board and we were delisted in 2006, although our shares
continued to be traded and reported in the Pink Sheets Electronic
Quotation Service. The defense of any such claims or proceedings may cause
the diversion of management’s attention and resources, and we may be
required to pay damages if any such claims or proceedings are not resolved
in our favor. Any litigation or regulatory proceeding, even if resolved in
our favor, could cause us to incur significant legal and other expenses.
We also may have difficulty raising equity capital or obtaining other
financing. We may not be able to effectuate our current business strategy.
The occurrence of any of the foregoing could harm our business and
reputation and cause the price of our securities to
decline.
|
|
•
|
|
WE
FACE RISKS RELATED TO LATE TAX FILINGS. The Company has not filed its
mandatory tax filling for the 2005, 2006 and 2007 [and 2008?] fiscal years
with the US Internal Revenue Service and the Commonwealth of Pennsylvania
Tax Department. Management believes that the potential liability to the
Company is not significant since the Company reported significant losses
for the respective years. Moreover, to the best of management’s knowledge,
the Company does not believe that not filing tax returns is a violation of
any of its contractual covenants. [The Company expects to file its tax
returns for all years during the fourth quarter of 2008.] [NEED UPDATE; HAS THIS BEEN
DONE?]
|
|
QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET
RISK
|
Not
applicable.
Evaluation
of Disclosure Controls and Procedures
The
Company carried out an evaluation, under the supervision and with the
participation of the Company’s management, of the effectiveness of the Company’s
internal control over financial reporting as of September 30, 2008. Based
on that evaluation, management has concluded that the Company’s controls over
the accounting of certain debt and equity transactions were ineffective. This
material weakness was attributed to lack of technical expertise with respect to
the application of Statement of Financial Accounting Standards No. 133,
“Accounting for Derivative Instruments and Hedging Activities,” as amended as
well as Statement of Financial Accounting Standards No. 150, “Accounting
for Certain Financial Instruments with Characteristics of Both Liabilities and
Equity,” and related accounting guidance.
As a
result, management concluded that the Company’s internal control over financial
reporting was not effective as of September 30, 2008.
The
Company acknowledges that certain weaknesses need to be addressed. The primary
reason for said deficiencies is a current and temporary lack of adequate
resources and personnel. The Company intends to take action to hire additional
staff and develop the adequate policies and procedures with said enhanced staff
to ensure that adequate internal controls are in place to allow for effective
and timely management and reporting.
Changes
in Internal Controls
There
were no changes in the Company’s internal control over financial reporting that
occurred during the quarter ended September 30, 2008 that have materially
affected, or are reasonably likely to materially affect, the Company’s internal
control over financial reporting.
OTHER
INFORMATION
The
Company entered into a Financial Advisory and Investment Banking Agreement with
North Coast Securities Corporation (“North Coast”) dated February 1, 2006.
Subsequent to the date of the Agreement North Coast asserted claims for unpaid
compensation under the Agreement. Counsel for North Coast have asserted a breach
of contract claim against the Company seeking warrants to purchase 500,000
shares of Company common stock with an exercise price of $0.04 per share and
$10,000 per month for the term of the Agreement for a total of $120,000. On
December 31, 2007 a lawsuit was filed in Montgomery County against the
Company in this matter. Management asserts that no services were rendered to
satisfy any compensation. The Court has dismissed the case with prejudice on
March 30th, 2009.
The Company was responsible for its own legal fees in this matter.
Andrew J.
Manning, a former employee of the Company, filed a complaint in October 2008, in
the Superior Court of New Jersey, Morris County, Law Division, against the
Company and other parties, alleging breach of contract, breach of covenant of
good faith and fair dealing, negligent misrepresentation, tortious interference
with Mr. Manning’s economic gain, retaliation, unjust enrichment, and
intentional infliction of emotional distress. The Company and management believe
that the allegations in the Complaint have no merit and the Company intends to
vigorously defend the suit. This matter has not been resolved as of the date
hereof.
From time
to time the Company is a defendant or plaintiff in various legal actions which
arise in the normal course of business. As such the Company is required to
assess the likelihood of any adverse outcomes to these matters as well as
potential ranges of probable losses. A determination of the amount of the
provision required for these commitments and contingencies, if any, which would
be charged to earnings, is made after careful analysis of each matter. The
provision may change in the future due to new developments or changes in
circumstances. Changes in the provision could increase or decrease the Company’s
earnings in the period the changes are made. In the opinion of management, after
consultation with legal counsel, the ultimate resolution of these matters will
not have a material adverse effect on the Company’s financial condition, results
of operations or cash flows.
As a
“smaller reporting company” as defined by Item 10 of Regulation S-K, the
Company is not required to provide information required by this
Item.
|
UNREGISTERED
SALES OF SECURITIES AND USE OF
PROCEEDS
|
The
Company closed on debt financings under the June 2008 Financing described herein
with seven institutional investors from October 6, 2008 to November 12,
2008 for a total of Euros 1,263,100 (approximately U.S.
$1,644,665). The Company did not pay any underwriting discounts or
commissions in connection with the issuance of the Convertible Notes in this
transaction. Issuance of the Convertible Notes were exempt from registration
under Section 4(2) of the Securities Act. The Convertible Notes were issued
to accredited investors in a private transaction without the use of any form of
general solicitation or advertising. The underlying securities are “restricted
securities” subject to applicable limitations on resale.
On
October 14, 2008 the Company signed a separation agreement with its Chief
Financial Officer, Amir Elbaz, and as part of this separation agreement the
Company approved the issuance of 1,500,000 shares of its Common Stock to Mr.
Elbaz. The shares have not yet been issued.
|
DEFAULTS
UPON SENIOR SECURITIES
|
None.
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY
HOLDERS
|
None.
None.
The
following Exhibits are filed as part of this Report or incorporated herein by
reference:
10.85
|
|
Asset
Purchase Agreement dated August ____, 2008 between the Company and Porous
Power Technologies, LLC +
|
|
|
10.86
|
|
Sublease
Agreement dated August 15, 2008 between the Company and Porous Power
Technologies, LLC +
|
|
|
31.1
|
|
Certification
of Chief Executive Officer and Acting Principal Financial Officer pursuant
to Section 302 of the Sarbanes Oxley Act of 2002 +
|
|
|
32.1
|
|
Certification
of Chief Executive Officer and Acting Principal Financial Officer pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 +
|
+
|
Exhibit
filed herewith in this Report.
|
(b)
|
Reports
on Form 8K. During the quarter ended September 30, 2008, we filed the
following Reports on Form 8-K:
|
We filed
a Report on Form 8K dated July 10, 2008, reporting on the issuance of a press
release announcing we had signed a memorandum of understanding (“MOU”) with
EnerSys, one of the world’s largest and most reputable battery
companies. The MOU calls for the establishment of a close
relationship on the advancement of large lithium ion batteries between the
parties.
SIGNATURES
In
accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
LITHIUM
TECHNOLOGY CORPORATION
|
|
|
|
|
Date:
April ____, 2009
|
|
|
|
BY:
|
|
/s/
Theo M. M. Kremers
|
|
|
|
|
|
|
|
|
Theo
M. M. Kremers
|
|
|
|
|
|
|
|
|
Chief
Executive Officer
|
|
|
|
|
|
|
|
|
(Principal
Executive Officer and Acting Principal Financial
Officer)
|
24